PROGRESSION FREE SURVIVAL AT 12 MONTHS AFTER FIRST‐LINE THERAPY IS ASSOCIATED WITH FAVOURABLE OUTCOMES AFTER FIRST RELAPSE/PROGRESSION IN PERIPHERAL T‐CELL LYMPHOMA. (12th June 2019) - Shirouchi, Y.; Yokoyama, M.; Fukuta, T.; Nishihara, A.; Inoue, N.; Uryu, H.; Kusano, Y.; Nishimura, N.; Mishima, Y.; Tsuyama, N.; Takeuchi, K.; Terui, Y.